Viremic relapse following HIV-1 remission in a perinatally infected child

Citation: Luzuriaga K, Gay H, Ziemniak C, Sanborn K, Somasundaran, Rainwater-Lovett K, Mellors J, Rosenbloom D. I.S, Persaud D. Viremic relapse following HIV-1 remission in a perinatally infected child. N Engl J Med. 2015 Feb 19;372(8):786-8. PMID 25693029; PMCID PMC4440331

Access full article:

https://www.ncbi.nlm.nih.gov/pubmed/25693029

Categories

CRS
Topics

Clinical Trials

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

P1108: A Phase I/II, Open-Label, Single Arm Study to...

This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...

Read More

P2026: Pharmacokinetic Properties of Antiretroviral and...

IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...

Read More

A5300B/I2003B/PHOENIX, Protecting Households On Exposure to...

This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More